Welcome to the Supply Chain & Logistics for Cell Therapies Summit
The only meeting uniting supply chain experts to advance the cell therapy supply chain and operations for seamless patient-led delivery.
Whilst cell therapies are changing the face of cancer treatments, a key challenge lies in having a resilient and patient-focused supply chain that remains robust throughout the commercialization process to ensure patient safety on a large scale.
Our 2022 Agenda Tackled the Following Challenges:
Optimize your cryopreservation processes and learn how to manage the operation of upscaling to a commercial scale to prepare for the treatment of large volumes of patients with BlueRock Therapeutics, GSK and Bayer Oncology
Solve your logistical issues and address concerns regarding chains of identity and custody to improve patient scheduling and safety through end-to-end systems with NIST, ICCBBA and Iovance
Discover how digital systems can help you manage your supply chain and optimize the link between your supply chain entities with GSK, Genentech and Lyell Immunopharma
learnings and how the key takeaways can develop and implement risk mitigation strategies for future uncertainties with Beam Therapeutics and
Moffitt Cancer Center
Network face-to-face with supply chain professionals and discuss the most relevant challenges to build solutions with the end-patient in mind
This summit is a unique opportunity to unite with your community and gain actionable insights to transform your supply chain into a seamless end-to-end operation.
Download the 2022 event guide to learn see what you missed.
‘The Supply Chain and Logistics for Cell Therapies Summit consistently delivers relevance for the sector with a shared sense of purpose and learning from an engaged faculty and audience’
Senior Director, Patient & Cell Management, Autolus
''It was great to connect with a like-minded and engaged community all trying to bring great therapies to patients’’
Information Technology Leading for Cell & Gene Therapy Industrialization, Manufacturing & Supply Chain Professional, Roche
‘‘Great visibility to the challenges we are all facing and an opportunity to see how different companies are tackling them’’
Cindy McNab, Associate Director, External Manufacturing, Supply Chain, Allogene Therapeutics
“This meeting provides an opportunity to collaborate with colleagues on supply chain topics that are unique to immunotherapies, in the interest of consistently delivering the highest quality products to our patients”
Kirstin Powel, Global Head, External Quality Operations, Novartis Cell